Crystal Growth & Design
Article
Figure 1. Chemical structures of three-dimensional p-type (3D-1 and 3D-2) and n-type (Spiro-8CN) molecules with 2D face-to-face packing.
washed with brine, dried with Na2SO4, and filtered. The filtrate was
concentrated under reduced pressure. After purification by column
2. EXPERIMENTAL SECTION
General Methods. 1H NMR and 13C NMR spectra were recorded
chromatography with eluent hexane/ethyl acetate (10:1), the desired
in CD2Cl2 or C2D2Cl4 on Bruker DPX 250 or 700 MHz instruments.
High-resolution MALDI mass spectrometry measurements were
performed on a Solarix ESI-/MALDI-ICR (9.4 T) system (Bruker
Daltonics, Germany). Density functional theory (DFT) calculations
compound 1 was obtained as a white solid in a yield of 74%. 1H NMR
(250 MHz, C2D2Cl4) δ/ppm: 7.88 (d, J = 7.9 Hz, 4H), 7.56 (d, J = 8.0
Hz, 4H), 7.38 (dd, J = 7.8, 1.7 Hz, 4H), 7.30 (dd, J = 8.3, 1.8 Hz, 4H),
7.25 (d, J = 1.9 Hz, 4H), 6.65 (s, 4H), 3.06 (s, 12H), 1.25 (s, 36H). 13C
were carried out with the Gaussian 09 program at the B3LYP/6-311G
NMR (63 MHz, CD2Cl2) δ/ppm: 169.36, 155.13, 149.18, 141.90,
(d, p) level. X-ray crystallographic data were collected on a STOE IPDS
141.85, 141.03, 130.06, 128.70, 128.60, 127.98, 124.82, 124.60, 120.54,
2T diffractometer with Cu Kα IμS mirror system. The structures were
66.28, 51.97, 35.26, 31.31. HRMS (TOF MS ES+): m/z calcd for
resolved by direct methods (SIR-2004) and refined by SHELXL-2014
(full matrix): 1005 refined parameters for Spiro-4O and 814 refined
parameters for Spiro-8CN.
Synthetic Details. All reagents and solvents used for synthesis were
C73H73O8 1077.5305, found 1077.5299.
2,2′,2″,2‴-(9,9′-Spirobi[fluorene]-2,2′,7,7′-tetrayl)tetrakis(4-
(tert-butyl)benzoic Acid) (2). A solution of sodium hydroxide (12 g in
45 mL water) was added dropwise into a suspension of compound 1 (2.3
obtained from commercial suppliers and used without further
g, 2.14 mmol) in 300 mL of ethanol. The resulting solution was stirred
purification. Column chromatography was performed on silica gel 60
for 12 h at 90 °C. After cooling to room temperature, the solution was
(Macherey-Nagel, Si60). 2,2′,7,7′-Tetrakis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-9,9′-spirobi[fluorene] was synthesized according to
a reported procedure.11 All reported yields are isolated yields.
concentrated under reduced pressure, and the residue was acidified with
concentrated hydrochloric acid. The white solid product was obtained
by filtration, followed by washing with water (1000 mL) and drying in
the vacuum oven. Finally, pure compound 2 was obtained in a yield of
99%. 1H NMR (250 MHz, CD2Cl2) δ/ppm: 7.84 (d, J = 7.7 Hz, 4H),
7.39 (dd, J = 12.9, 8.0 Hz, 8H), 7.29 (d, J = 8.5 Hz, 4H), 7.27 (s, 4H),
6.59 (s, 4H), 1.22 (s, 36H). 13C NMR (63 MHz, CD2Cl2) δ/ppm:
176.32, 154.99, 148.70, 141.90, 141.84, 141.13, 129.56, 128.37, 128.23,
127.45, 124.58, 124.53, 120.63, 66.35, 35.26, 31.21. HRMS (TOF MS
ES+): m/z calcd for C69H65O8 1021.4679, found 1021.4704.
3,3′,9,9′-Tetra-tert-butyl-6,6′-spirobi[cyclopenta[2,1-b:3,4-
b′]difluorene]-12,12′,15,15′-tetraone (Spiro-4O). Dry DMF (0.07
mL) was added dropwise to a solution of 2 (0.60 g, 0.59 mmol) and 2
mol/L oxalyl chloride (6 mL, 12 mmol) in dry DCM (120 mL). The
mixture was stirred for 10 h at room temperature. The solvent was
evaporated under reduced pressure. The residue was dissolved in 30 mL
of dry DCM and added to a suspension of anhydrous AlCl3 (848 mg, 4.8
mmol) in dry DCM (100 mL) at 0 °C. After 12 h later, the reaction
mixture was poured into ice water slowly, extracted with DCM (80 × 3
mL), dried with Na2SO4, and filtered. The solvent was removed, and the
crude product was purified by column chromatography, using eluent
ethyl acetate (20:1) to give Spiro-4O as a yellow solid in a yield of 82%
(0.46 g). 1H NMR (700 MHz, C2D2Cl4) δ/ppm: 8.19 (s, 4H), 7.55 (d, J
= 7.8 Hz, 4H), 7.27 (s, 4H), 7.24 (d, J = 7.8 Hz, 4H), 6.93 (s, 4H), 1.19
(s, 36H). 13C NMR (63 MHz, C2D2Cl4) δ/ppm: 192.54, 159.65, 153.64,
145.44, 143.83, 141.74, 135.94, 132.08, 126.64, 124.44, 117.94, 116.37,
116.12, 66.42, 35.55, 31.02. HRMS (TOF MS ES+): m/z calc. for
C69H57O4 949.4257, found 949.4249.
Methyl 2-Bromo-4-(tert-butyl)benzoate. NaOH (15.12 g, 0.38
mol) was dissolved in 140 mL of water, followed by the dropwise
addition of bromine (5.00 mL, 0.10 mol) in an ice bath. Next, a solution
of 1-(2-bromo-4-(tert-butyl)phenyl)ethan-1-one (6.20 g, 0.024 mol) in
120 mL of dioxane was slowly added. After 12 h, the solution was
acidified with concentrated hydrochloric acid and extracted with ethyl
acetate (150 × 3 mL). The combined organic layers were washed with
water (200 mL) and brine (200 mL) separately, and dried with Na2SO4.
The solvent was removed under reduced pressure to give crude product
2-bromo-4-(tert-butyl)benzoic acid, which was purified by column
chromatography with the eluent hexane/ethyl acetate (4:1). This
obtained pure precursor was added into a flask with 500 mL of methanol,
followed by the dropwise of concentrated sulfuric acid (2.0 mL). The
mixture was heated to reflux overnight. After cooling to room
temperature, the solution was concentrated, poured into water (300
mL), and extracted with DCM (200 × 3 mL). The combined organic
phases were washed with saturated NaHCO3 (50 × 2 mL) and dried
with Na2SO4. After filtration, the filtrate was concentrated to give the
1
pure methyl 2-bromo-4-(tert-butyl)benzoate in a 90% yield. H NMR
(250 MHz, CD2Cl2) δ/ppm: 7.78 (d, J = 8.2 Hz, 1H), 7.72 (d, J = 1.9 Hz,
1H), 7.44 (dd, J = 8.2, 1.9 Hz, 1H), 3.93 (s, 3H), 1.36 (s, 9H). 13C NMR
(62.5 MHz, CD2Cl2) δ/ppm: 166.66, 157.18, 131.92, 131.50, 129.44,
124.83, 121.87, 52.56, 35.28, 31.05. HRMS (TOF MS ES+): m/z calcd
for C12H15O2NaBr 293.0153, found 293.0164.
Tetramethyl 2,2′,2″,2‴-(9,9′-Spirobi[fluorene]-2,2′,7,7′-
tetrayl)tetrakis(4-(tert-butyl)benzoate) (1). A mixture of 2,2′,7,7′-
tetrakis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9,9′-spirobi-
[fluorene] (2.31 g, 2.89 mmol), methyl 2-bromo-4-(tert-butyl)benzoate
(3.6 g, 13.28 mmol), tetrakis(triphenylphosphine)palladium(0) (667
mg, 0.58 mmol), 2 M aqueous potassium carbonate solution (50 mL),
and toluene (200 mL) was stirred for 2 days at 110 °C under argon
atmosphere. After cooling to room temperature, the mixture was
extracted with DCM (80 × 3 mL). The obtained organic layers were
2,2′,2″,2‴-(3,3′,9,9′-Tetra-tert-butyl-6,6′-spirobi[cyclopenta-
[2,1-b:3,4-b′]difluorene]-12,12′,15,15′-tetraylidene)tetra-
malononitrile (Spiro-8CN). Spiro-4O (0.20 g, 0.21 mmol) and
malononitrile (1.39 g, 21 mmol) were dissolved in dry CHCl3 (80 mL)
under argon atmosphere. TiCl4 (2.3 mL, 21.0 mmol) and pyridine (2.49
mL) were added dropwise. The mixture was stirred overnight at 80 °C.
After the removal of solvent, the residue was subjected to column
chromatography, using pure DCM as eluent to afford product Spiro-
B
Cryst. Growth Des. XXXX, XXX, XXX−XXX